Avenzo Therapeutics
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $150.0Mattributed |
|---|---|
| Latest round | series-a, $150.0M, 2024-03-01attributed |
| Founded | unknown |
| Headquarters | San Diego CA |
| Industry | biotech|oncology|therapeutics |
| Stage | series-a |
| Website | avenzotx.com |
Clinical-stage oncology biotech advancing next-generation therapies for solid tumors. Works on programs aimed at improving outcomes versus current standard-of-care chemo and targeted therapy. Builds an in-licensing-led pipeline rather than a single-platform model.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-03-01 | series-a | $150.0M | nea |
Detected tech stack
Cloudflare, All in One SEO 4.9.6.2, All in One SEO Pack 4.9.6.2, Unpkg, Kinsta, reCAPTCHA, Gravity Forms 2.10.1, jQuery Migrate 3.4.1, PHP, cdnjs, Cloudflare Bot Management, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $150.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $150.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | avenzotx.com, read 2026-05-05 |
| Description | self-reported | avenzotx.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.